Skip to main content
123 Results For "leishmaniasis"
 
msf-placeholder
Neglected diseases

Kala azar kills thousands each year

MSF has tested a new rapid diagnostic tool: a dipstick that reacts with antibodies against the kala-azar parasite found in a drop of a patient's blood. The test has been found to give a correct, positive outcome in 90 percent of infected patients. The dipstick is specially designed for use in areas lacking laboratories or hospitals. Project Update - 10 Nov 2006
 
msf-placeholder
Ethiopia

Better access to treatment for Ethiopian kala azar patients

Up until now the bulk of the kala-azar patients were dependent on MSF or research institutions for medical care. MSF has treated more than 9,300 patients since the start of its kala-azar programmes in 1997. Project Update - 6 Mar 2006
 
msf-placeholder
Tsunami

Use of tsunami funds

A summary of the use of tsunami funds Project Update - 20 Dec 2005
 
msf-placeholder
Malaria

Two new malaria treatments available in 2006

First medicines developed by Drugs for Neglected Diseases Initiative (DNDi) will be easier to use and less expensive than current ACTs, but action is needed to make sure the treatments reach patients. Press Release - 13 Dec 2005
 
msf-placeholder
Colombia

The ghost town in Colombia that steals your sleep

One of the area's long-time leaders, a key promoter of the community's return to Saiza five years after the massacre, admits that the first time he rediscovered sleep in this tormented town was in June 2005, when Médecins Sans Frontières (MSF) established a permanent presence in the town. Project Update - 16 Aug 2005
 
msf-placeholder
Ethiopia

Kala azar outbreak in Ethiopia as rainy season begins

A severe outbreak of kala azar, a rare and fatal disease, has struck the region of Amhara, northwest Ethiopia. In the small rural community of Bura (pop: 6,000) more than 150 people have died and over 230 infected persons have already been recorded. Project Update - 27 Jun 2005
 
msf-placeholder
Tuberculosis

Global appeal for new treatments for neglected diseases is launched

Médecins Sans Frontières, other non-governmental organisations, scientists and a number of Nobel laureates around the world today joined the Drugs for Neglected Diseases Initiative in a global appeal to focus research on developing new drugs, diagnostic tests and vaccines for diseases of the poor. Press Release - 8 Jun 2005
 
msf-placeholder
HIV/AIDS

The gap is growing: More resources needed now for neglected diseases

The pipeline of drugs for neglected diseases is virtually empty. From 1975 to 1999 of the 1393 new drugs marketed only 13, or a mere one per cent, were for tropical diseases. This imbalance is unacceptable in the second millennium.New drugs for neglected diseases: From pipeline to patients in PDF format. Press Release - 11 Nov 2004
 
msf-placeholder
Kala azar

Drugs for Neglected Diseases Initiative (DNDi): matching needs and opportunities

Neglected diseases such as leishmaniasis, trypanosomiasis, Chagas disease and malaria have a devastating impact on the world's poor. Project Update - 2 Jul 2004
 
msf-placeholder
Malaria

Malaria patients enter DNDi clinical trials

To ensure a balanced portfolio of drugs in the pipeline, DNDi mixes quick-fix with long-term projects. In the short term, DNDi is developing "fixed-dose" combinations (two drugs combined into one tablet) for uncomplicated malaria: artesunate/amodiaquine for use in Africa and artesunate/mefloquine for use in Asia and Latin America. Press Release - 2 Jul 2004
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more